{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:58:10Z","timestamp":1765040290826},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T00:00:00Z","timestamp":1282867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/cdd.2010.101","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T09:04:19Z","timestamp":1282899859000},"page":"304-314","source":"Crossref","is-referenced-by-count":33,"title":["SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence"],"prefix":"10.1038","volume":"18","author":[{"given":"X D","family":"Wang","sequence":"first","affiliation":[]},{"given":"E","family":"Lapi","sequence":"additional","affiliation":[]},{"given":"A","family":"Sullivan","sequence":"additional","affiliation":[]},{"given":"I","family":"Ratnayaka","sequence":"additional","affiliation":[]},{"given":"R","family":"Goldin","sequence":"additional","affiliation":[]},{"given":"R","family":"Hay","sequence":"additional","affiliation":[]},{"given":"X","family":"Lu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,8,27]]},"reference":[{"key":"BFcdd2010101_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1006103831990","volume":"52","author":"DM Barnes","year":"1998","unstructured":"Barnes DM, Gillett CE . Cyclin D1 in breast cancer. Breast Cancer Res Treat 1998; 52: 1\u201315.","journal-title":"Breast Cancer Res Treat"},{"key":"BFcdd2010101_CR2","first-page":"261","volume":"16","author":"A Shamma","year":"2000","unstructured":"Shamma A, Doki Y, Shiozaki H, Tsujinaka T, Yamamoto M, Inoue M et al. Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. Int J Oncol 2000; 16: 261\u2013266.","journal-title":"Int J Oncol"},{"key":"BFcdd2010101_CR3","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1101\/gad.7.8.1559","volume":"7","author":"DE Quelle","year":"1993","unstructured":"Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes & Dev 1993; 7: 1559\u20131571.","journal-title":"Genes & Dev"},{"key":"BFcdd2010101_CR4","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1128\/MCB.14.3.1669","volume":"14","author":"D Resnitzky","year":"1994","unstructured":"Resnitzky D, Gossen M, Bujard H, Reed SI . Acceleration of the G1\/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994; 14: 1669\u20131679.","journal-title":"Mol Cell Biol"},{"key":"BFcdd2010101_CR5","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","volume":"12","author":"JA Diehl","year":"1998","unstructured":"Diehl JA, Cheng M, Roussel MF, Sherr CJ . Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes & Dev 1998; 12: 3499\u20133511.","journal-title":"Genes & Dev"},{"key":"BFcdd2010101_CR6","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1101\/gad.854900","volume":"14","author":"JR Alt","year":"2000","unstructured":"Alt JR, Cleveland JL, Hannink M, Diehl JA . Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes & Dev 2000; 14: 3102\u20133114.","journal-title":"Genes & Dev"},{"key":"BFcdd2010101_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/sj.onc.1209147","volume":"25","author":"AB Gladden","year":"2006","unstructured":"Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA . Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene 2006; 25: 998\u20131007.","journal-title":"Oncogene"},{"key":"BFcdd2010101_CR8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/sj.onc.1210738","volume":"27","author":"DI Lin","year":"2008","unstructured":"Lin DI, Lessie MD, Gladden AB, Bassing CH, Wagner KU, Diehl JA . Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 2008; 27: 1231\u20131242.","journal-title":"Oncogene"},{"key":"BFcdd2010101_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.biochem.73.011303.074118","volume":"73","author":"ES Johnson","year":"2004","unstructured":"Johnson ES . Protein modification by SUMO. Annu Rev Biochem 2004; 73: 355\u2013382.","journal-title":"Annu Rev Biochem"},{"key":"BFcdd2010101_CR10","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.1074\/jbc.275.9.6252","volume":"275","author":"H Saitoh","year":"2000","unstructured":"Saitoh H, Hinchey J . Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2\/3. J Biol Chem 2000; 275: 6252\u20136258.","journal-title":"J Biol Chem"},{"key":"BFcdd2010101_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1074\/mcp.M700173-MCP200","volume":"7","author":"I Matic","year":"2008","unstructured":"Matic I, van Hagen M, Schimmel J, Macek B, Ogg SC, Tatham MH et al. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics 2008; 7: 132\u2013144.","journal-title":"Mol Cell Proteomics"},{"issue":"Pt 6","key":"BFcdd2010101_CR12","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1042\/BST0351409","volume":"35","author":"J Anckar","year":"2007","unstructured":"Anckar J, Sistonen L . SUMO: getting it on. Biochem Soc Trans 2007; 35 (Pt 6): 1409\u20131413.","journal-title":"Biochem Soc Trans"},{"key":"BFcdd2010101_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0959-437X(98)80060-9","volume":"8","author":"AC Lloyd","year":"1998","unstructured":"Lloyd AC . Ras versus cyclin-dependent kinase inhibitors. Curr Opin Genet Dev 1998; 8: 43\u201348.","journal-title":"Curr Opin Genet Dev"},{"key":"BFcdd2010101_CR14","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1038\/sj.onc.1202880","volume":"18","author":"C Pantoja","year":"1999","unstructured":"Pantoja C, Serrano M . Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 1999; 18: 4974\u20134982.","journal-title":"Oncogene"},{"key":"BFcdd2010101_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593\u2013602.","journal-title":"Cell"},{"key":"BFcdd2010101_CR16","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1038\/sj.emboj.7600789","volume":"24","author":"T Sebastian","year":"2005","unstructured":"Sebastian T, Malik R, Thomas S, Sage J, Johnson PF . C\/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. EMBO J 2005; 24: 3301\u20133312.","journal-title":"EMBO J"},{"key":"BFcdd2010101_CR17","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/ncb1988","volume":"11","author":"X Guo","year":"2009","unstructured":"Guo X, Keyes WM, Papazoglu C, Zuber J, Li W, Lowe SW et al. TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 2009; 11: 1451\u20131457.","journal-title":"Nat Cell Biol"},{"key":"BFcdd2010101_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1097-2765(01)00367-7","volume":"8","author":"Y Samuels-Lev","year":"2001","unstructured":"Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 2001; 8: 781\u2013794.","journal-title":"Mol Cell"},{"key":"BFcdd2010101_CR19","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1101\/gad.374006","volume":"20","author":"V Vives","year":"2006","unstructured":"Vives V, Su J, Zhong S, Ratnayaka I, Slee E, Goldin R et al. ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes & Dev 2006; 20: 1262\u20131267.","journal-title":"Genes & Dev"},{"key":"BFcdd2010101_CR20","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1073\/pnas.0809080106","volume":"106","author":"KM Kampa","year":"2009","unstructured":"Kampa KM, Acoba JD, Chen D, Gay J, Lee H, Beemer K et al. Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds. Proc Natl Acad Sci USA 2009; 106: 4390\u20134395.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2010101_CR21","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.febslet.2005.01.069","volume":"579","author":"ZJ Liu","year":"2005","unstructured":"Liu ZJ, Lu X, Zhang Y, Zhong S, Gu SZ, Zhang XB et al. Downregulated mRNA expression of ASPP and the hypermethylation of the 5\u2032-untranslated region in cancer cell lines retaining wild-type p53. FEBS Letters 2005; 579: 1587\u20131590.","journal-title":"FEBS Letters"},{"key":"BFcdd2010101_CR22","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1080\/1042819021000040017","volume":"43","author":"IS Lossos","year":"2002","unstructured":"Lossos IS, Natkunam Y, Levy R, Lopez CD . Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome. Leuk Lymphoma 2002; 43: 2309\u20132317.","journal-title":"Leuk Lymphoma"},{"key":"BFcdd2010101_CR23","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1038\/sj.onc.1202904","volume":"18","author":"JP Yang","year":"1999","unstructured":"Yang JP, Hori M, Takahashi N, Kawabe T, Kato H, Okamoto T . NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene 1999; 18: 5177\u20135186.","journal-title":"Oncogene"},{"key":"BFcdd2010101_CR24","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1128\/MCB.16.7.3884","volume":"16","author":"L Naumovski","year":"1996","unstructured":"Naumovski L, Cleary ML . The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2\/M. Mol Cell Biol 1996; 16: 3884\u20133892.","journal-title":"Mol Cell Biol"},{"key":"BFcdd2010101_CR25","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/emboj\/16.8.1876","volume":"16","author":"MP Egloff","year":"1997","unstructured":"Egloff MP, Johnson DF, Moorhead G, Cohen PT, Cohen P, Barford D . Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J 1997; 16: 1876\u20131887.","journal-title":"EMBO J"},{"key":"BFcdd2010101_CR26","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.1074\/jbc.M008568200","volume":"276","author":"X Espanel","year":"2001","unstructured":"Espanel X, Sudol M . YES-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J Biol Chem 2001; 276: 14514\u201314523.","journal-title":"J Biol Chem"},{"key":"BFcdd2010101_CR27","first-page":"101","volume":"60","author":"H Nakagawa","year":"2000","unstructured":"Nakagawa H, Koyama K, Murata Y, Morito M, Akiyama T, Nakamura Y . APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus. Cancer Res 2000; 60: 101\u2013105.","journal-title":"Cancer Res"},{"key":"BFcdd2010101_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1083\/jcb.200304003","volume":"163","author":"Y Chen","year":"2003","unstructured":"Chen Y, Liu W, McPhie DL, Hassinger L, Neve RL . APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain. J Cell Biol 2003; 163: 27\u201333.","journal-title":"J Cell Biol"},{"key":"BFcdd2010101_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ccr.2008.05.017","volume":"14","author":"O Barbash","year":"2008","unstructured":"Barbash O, Zamfirova P, Lin DI, Chen X, Yang K, Nakagawa H et al. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 2008; 14: 68\u201378.","journal-title":"Cancer Cell"},{"key":"BFcdd2010101_CR30","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1371\/journal.pone.0000128","volume":"1","author":"H Okabe","year":"2006","unstructured":"Okabe H, Lee SH, Phuchareon J, Albertson DG, McCormick F, Tetsu O . A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PloS One 2006; 1: e128.","journal-title":"PloS One"},{"issue":"Web Server issu","key":"BFcdd2010101_CR31","doi-asserted-by":"publisher","first-page":"W254","DOI":"10.1093\/nar\/gkl207","volume":"34","author":"Y Xue","year":"2006","unstructured":"Xue Y, Zhou F, Fu C, Xu Y, Yao X . SUMOsp: a web server for SUMOylation site prediction. Nucleic Acids Res 2006; 34 (Web Server issue): W254\u2013W257.","journal-title":"Nucleic Acids Res"},{"key":"BFcdd2010101_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2006.09.007","volume":"24","author":"DI Lin","year":"2006","unstructured":"Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ et al. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol Cell 2006; 24: 355\u2013366.","journal-title":"Mol Cell"},{"key":"BFcdd2010101_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J . Targeting RAS signalling pathways in cancer therapy. Nat Rev 2003; 3: 11\u201322.","journal-title":"Nat Rev"},{"key":"BFcdd2010101_CR34","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1101\/gad.11.8.957","volume":"11","author":"JA Diehl","year":"1997","unstructured":"Diehl JA, Zindy F, Sherr CJ . Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997; 11: 957\u2013972.","journal-title":"Genes Dev"},{"key":"BFcdd2010101_CR35","doi-asserted-by":"publisher","first-page":"56061","DOI":"10.1074\/jbc.M411910200","volume":"279","author":"S Benzeno","year":"2004","unstructured":"Benzeno S, Diehl JA . C-terminal sequences direct cyclin D1-CRM1 binding. J Biol Chem 2004; 279: 56061\u201356066.","journal-title":"J Biol Chem"},{"key":"BFcdd2010101_CR36","doi-asserted-by":"publisher","first-page":"12654","DOI":"10.1074\/jbc.M009476200","volume":"276","author":"MS Rodriguez","year":"2001","unstructured":"Rodriguez MS, Dargemont C, Hay RT . SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem 2001; 276: 12654\u201312659.","journal-title":"J Biol Chem"},{"key":"BFcdd2010101_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ijc.2910570311","volume":"57","author":"J Bartkova","year":"1994","unstructured":"Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J . Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994; 57: 353\u2013361.","journal-title":"Int J Cancer"},{"key":"BFcdd2010101_CR38","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1128\/MCB.22.10.3389-3403.2002","volume":"22","author":"W Wang","year":"2002","unstructured":"Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S et al. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3\/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 2002; 22: 3389\u20133403.","journal-title":"Mol Cell Biol"},{"key":"BFcdd2010101_CR39","doi-asserted-by":"publisher","first-page":"9007","DOI":"10.1038\/sj.onc.1208088","volume":"23","author":"EA Slee","year":"2004","unstructured":"Slee EA, Gillotin S, Bergamaschi D, Royer C, Llanos S, Ali S et al. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization. Oncogene 2004; 23: 9007\u20139016.","journal-title":"Oncogene"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd2010101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2010101","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2010101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:47:46Z","timestamp":1684417666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2010101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,27]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["BFcdd2010101"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2010.101","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,27]]}}}